OR1L8 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the olfactory receptor 1L8 (OR1L8). Olfactory receptors, like OR1L8, are part of the G protein-coupled receptor (GPCR) family, primarily involved in detecting volatile compounds and enabling the sense of smell. These receptors play a key role in transducing chemical signals from odorants into neural signals through the binding of specific molecules. OR1L8, in particular, is one of the many olfactory receptors responsible for this molecular recognition process. Inhibition of OR1L8 can affect its ability to bind to specific ligands or alter the downstream signaling pathways. The inhibitors of OR1L8 act by either directly binding to the receptor site, preventing the interaction with its natural odorant ligands, or by interacting with associated signaling proteins that modulate its activity.
The structural diversity of OR1L8 inhibitors is notable, as these molecules must fit within the unique binding pocket of the OR1L8 receptor, which is shaped by the receptor's tertiary structure and amino acid composition. Typically, these inhibitors are small molecules that exhibit a high degree of specificity for OR1L8 over other olfactory receptors. This specificity is often achieved by designing or selecting compounds that exhibit favorable binding affinities to the receptor's active or allosteric sites. The understanding of OR1L8's three-dimensional structure and the dynamics of its binding site are crucial for the development of effective inhibitors. Additionally, OR1L8 inhibitors may influence not only ligand binding but also receptor dimerization, desensitization, or internalization processes, all of which are important aspects of GPCR function. Through studying these inhibitors, researchers can gain deeper insights into the receptor's role in olfactory signaling pathways and broader biochemical mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
Calcium chelator that can prevent calcium-mediated signal transduction in olfactory neurons, thus indirectly inhibiting OR1L8 activity. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Blocks L-type calcium channels, likely affecting calcium influx and subsequent signaling in olfactory neurons, impacting OR1L8 function. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $50.00 $128.00 | ||
Sodium channel blocker that can inhibit action potential propagation in neurons, potentially reducing OR1L8-mediated signaling. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
Inhibits CaM kinase II, an enzyme involved in the calcium signaling pathways, possibly affecting OR1L8-related signaling. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, which can increase cAMP levels, thereby potentially influencing the signaling cascade associated with OR1L8. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $97.00 $144.00 $648.00 | 47 | |
Inhibits protein kinase A, which is involved in cAMP-dependent signaling pathways, potentially affecting OR1L8 function. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $149.00 $210.00 $714.00 $2550.00 $10750.00 $21410.00 $40290.00 | 5 | |
Inhibits G protein activation, which could alter G protein-coupled receptor signaling, relevant to olfactory receptors like OR1L8. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
Blocks IP3 receptors and could disrupt intracellular calcium release, which is important for signal transduction in olfactory neurons, including OR1L8. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $88.00 $311.00 | 17 | |
Inhibits protein kinase C, an enzyme that plays a role in GPCR signaling, which can affect OR1L8 activity. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
Inhibits myosin light chain kinase, which can affect cytoskeletal changes and cellular processes relevant to OR1L8 signaling. | ||||||